Synteract
Morrisville · Founded 1986
About Synteract
Synteract®, a Syneos Health® company, is a leading full service CRO focused on the emerging biopharma segment. The Company’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccine, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries. To learn more about how Synteract is Bringing clinical trials to lifeTM by transforming insights to action and making therapies a reality, visit synteract.com and connect on LinkedIn and Twitter.
Company Facts
- Founded: 1986
- Legal name: Synteract, Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $50K – $100K
- Total funding: $3.0M
- Funding stage: M&A
- Last round: Private Equity (Feb 2014)
- Website: synteract.com
Social Profiles
Canonical: https://fsome.com/organization/synteract-8351334 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.